NanoViricides is trading at $1.68 (-5.28%) following a sharp move lower in early trading despite a lack of company-specific news, filings, or analyst actions.
- The decline appears consistent with idiosyncratic volatility typical of thinly traded microcaps rather than a fundamental catalyst.
- Broader biotech sentiment is notably weak, with the XBI down 3.00% as risk-off pressure impacts growth-oriented stocks.